During the past decade, Bristol Heart Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bristol Heart Institute" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "University of Bristol" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Atrium Medical Corporation" with 1 trials sponsored and "Biosense Webster, Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bristol Heart Institute" #1 collaborator was "University Hospitals Bristol and Weston NHS Foundation Trust" with 2 trials as a collaborator, "Blackpool Victoria Hospital" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator, "British Medical Association" with 1 trials as a collaborator and "Cardialysis B.V." with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Bristol Heart Institute" are "Coronary Artery Disease" (4 trials), "Heart Failure" (2 trials), "STEMI" (2 trials), "Acute Anterior Myocardial Infarction" (1 trials) and "Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "Bristol Heart Institute" in a lesser frequency.

Most popular intervention types in "Bristol Heart Institute" are "Device" (5 trials), "Procedure" (5 trials), "Drug" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "(BMS/DES)" (1 trials), "Abciximab local infusion" (1 trials), "Absorb BVS" (1 trials), "Aspirin" (1 trials) and "Blood markers" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bristol Heart Institute" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bristol Heart Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Bristol Heart Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bristol Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".